Records 1 - 30 (of 1243 Records) |
Query Trace: Vaccines[original query] |
---|
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) China, 2020
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team et al. China CDC Weekly 2020 10.46234/ccdcw2020.032
Summary:
Not in Science Update
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Epidemiological and Clinical Predictors of COVID-19.
Sun Yinxiaohe, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020 0 0. (15) 786-792
Key findings:
|
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
To Kelvin Kai-Wang, et al. The Lancet. Infectious diseases 2020 0 0. (5) 565-574
Key findings:
|
Developing Covid-19 Vaccines at Pandemic Speed.
Lurie Nicole, et al. The New England journal of medicine 2020 0 0. (21) 1969-1973
Summary:
Overview of accelerated SARS-CoV-2 vaccine development and the status of specific vaccine candidates.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study.
Giacomelli Andrea, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020 0 0. (15) 889-890
Key findings:
|
Flattening the Curve for Incarcerated Populations - Covid-19 in Jails and Prisons.
Akiyama Matthew J, et al. The New England journal of medicine 2020 0 0. (22) 2075-2077
Summary:
The better the mitigation job done by legal, public health, and correctional health partnerships, the lighter the burden correctional facilities and their surrounding communities will bear.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Ten Weeks to Crush the Curve.
Fineberg Harvey V, et al. The New England journal of medicine 2020 0 0. (17) e37
Summary:
Six points to crush the curve in 10 weeks: 1. Unified command, 2. Increased testing, 3. PPE/equipment for healthcare workers, 4. Triage population into 5 groups, 5. Mobilize the public, 6. Real-time fundamental research.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-2
Shi, Jianzhong et al.bioRxiv 10.1101/2020.03.30.015347
Key findings:
|
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen Chenguang, et al. JAMA 2020 0 0. (16) 1582-1589
Key findings:
|
Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing.
Ferretti Luca, et al. Science (New York, N.Y.) 2020 0 0. (6491)
Key findings:
|
Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness.
Druss Benjamin G, et al. JAMA psychiatry 2020 0 0. (9) 891-892
Summary:
Describes strategies to mitigate the outcome of this epidemic among patients with serious mental illness.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Ensuring Access to Medications in the US During the COVID-19 Pandemic.
Alexander G Caleb, et al. JAMA 2020 0 0. (1) 31-32
Summary:
Recommendations to address potential disruption of medication availability during the pandemic.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Pandemic school closures: risks and opportunities.
The Lancet Child Adolescent Health, et al. The Lancet. Child & adolescent health 2020 0 0. (5) 341
Summary:
With at least 188 countries implementing country-wide school closures, the editors review the impact on children and their caregivers.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Potential Shortages of Hydroxychloroquine for Patients with Lupus During the Coronavirus Disease 2019 Pandemic
Mehta, Bella et al.JAMA Health Forum 10.1001/jamahealthforum.2020.0438
Summary:
Brings attention to how shortages of hydroxychloroquine (HCQ) might affect socioeconomically vulnerable patients with lupus treated with HCQ and in remission.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment.
Leung Kathy, et al. Lancet (London, England) 2020 0 0. (10233) 1382-1393
Key findings:
|
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2.
Sanche Steven, et al. Emerging infectious diseases 2020 0 0. (7) 1470-1477
Key findings:
|
Governmental Public Health Powers During the COVID-19 Pandemic: Stay-at-home Orders, Business Closures, and Travel Restrictions.
Gostin Lawrence O, et al. JAMA 2020 0 0. (21) 2137-2138
Summary:
Discusses the balance between public health objectives and individual rights in implementation of COVID-19 response activities in the United States.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Chest Computed Tomography for Detection of Coronavirus Disease 2019 (COVID-19): Don't Rush the Science.
Hope Michael D, et al. Annals of internal medicine 2020 0 0. (2) 147-148
Summary:
Drawing on publications describing the use of chest CT for diagnosing COVID-19, authors discuss the importance of not rushing the science, even during the COVID-19 pandemic.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Lockdown Contained the Spread of 2019 Novel Coronavirus Disease in Huangshi City, China: Early Epidemiological Findings.
Ji Tuo, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020 0 0. (6) 1454-1460
Key findings:
|
A Bold Response to the COVID-19 Pandemic: Medical Students, National Service, and Public Health.
Bauchner Howard, et al. JAMA 2020 0 0. (18) 1790-1791
Summary:
Authors propose suspending medical school for incoming students, instead starting them in a public health service program to increase capacity at the local/state levels for community surveillance and response.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Finding Effective Treatments for COVID-19: Scientific Integrity and Public Confidence in a Time of Crisis.
Goodman Jesse L, et al. JAMA 2020 0 0. (19) 1899-1900
Summary:
Speaks to the importance of maintaining scientific integrity and public confidence, given how intense pressure and hope are combing to start ill-advised & uncontrolled human experimentation with unproven treatments.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Drug Evaluation during the Covid-19 Pandemic.
Rome Benjamin N, et al. The New England journal of medicine 2020 0 0. (24) 2282-2284
Summary:
Discusses the need to act as efficiently and as quickly as possible while maintaining the highest scientific standards to issue guidelines and to find effective treatments, with discussion focused on FDAs EUA for hydroxychloroquine.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Sanders James M, et al. JAMA 2020 0 0. (18) 1824-1836
Summary:
Literature review of the current evidence for different treatment options, including select repurposed drugs, investigational drugs, and adjunctive therapies.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.
Pan An, et al. JAMA 2020 0 0. (19) 1915-1923
Key findings:
|
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.
Okba Nisreen M A, et al. Emerging infectious diseases 2020 0 0. (7) 1478-1488
Summary:
Commercial tests for anti-SARS-CoV-2 IgG and IgA produced false-positive results when used to test serum samples from patients with other coronavirus infections, including common seasonal human coronaviruses (HCoV) that generally cause of mild human illness (gold arrows) and SARS-CoV-1 (cause of SARS, blue arrows) (Figure).
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
To streamline coronavirus vaccine and drug efforts, NIH and firms join forces
Kaiser, Jocelyn et al. Science Magazine 2020
Summary:
Describes the ACTIV initiative, a public-private partnership between NIH, pharma, and biotech companies to coordinate efforts to conduct clinical trials of drugs and vaccines.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19.
Magagnoli Joseph, et al. medRxiv : the preprint server for health sciences 2020 0 0.
Key findings:
|
The Promise and Peril of Antibody Testing for COVID-19.
Abbasi Jennifer, et al. JAMA 2020 0 0. (19) 1881-1883
Summary:
Discusses serologic testing, including implications for immunity, treatment with convalescent plasma, return to work, and regulatory issues.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
Crushing coronavirus means breaking the habits of a lifetime. Behavior scientists have some tips
Cornwall, Warren et al. Science Magazine 2020
Summary:
Notes how government and industry leaders are turning to behavioral scientists for advice on how to persuade people to abide by public health interventions.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
From Mitigation to Containment of the COVID-19 Pandemic: Putting the SARS-CoV-2 Genie Back in the Bottle.
Walensky Rochelle P, et al. JAMA 2020 0 0. (19) 1889-1890
Summary:
Discusses timing and logistics of resuming normal activities, the role of testing, and protection of vulnerable populations.
Visit Weekly CDC COVID-19 Science Update site for the full summary.
|
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 23, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure